NF1 and malignant peripheral nerve sheath tumor: In 2009, Karabatsou et al. [17] evaluated the role of FDG-PET/CT in differentiating benign neurofibroma from MPNST associated with NF1 and in defining regions of suspected PNF where malignant transformation may have started.